 | • レポートコード：TPM-B04022 • 出版社/出版日：Transparency Market Research / 2018年1月 • レポート形態：英文、PDF、162ページ • 納品方法：Eメール • 産業分類：製薬・医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、トロンビンの世界市場について調べ、トロンビンの世界規模、市場動向、市場環境、製品別分析、形態別分析、最終用途別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・トロンビンの世界市場動向 ・トロンビンの世界市場環境 ・トロンビンの世界市場規模 ・トロンビンの世界市場規模：製品別 ・トロンビンの世界市場規模：形態別 ・トロンビンの世界市場規模：最終用途別 ・トロンビンの世界市場：地域別市場規模・分析 ・トロンビンの北米市場規模・予測 ・トロンビンのアメリカ市場規模・予測 ・トロンビンのヨーロッパ市場規模・予測 ・トロンビンのアジア市場規模・予測 ・トロンビンの日本市場規模・予測 ・トロンビンの中国市場規模・予測 ・競争状況・関連企業情報 |
REPORT DESCRIPTION
Global Thrombin Market: Overview
This report on thrombin market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacturing and commercialization of thrombin products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global thrombin market with respect to the leading market segments based on major product segment, dosage form segment, and end users segment.
Global Thrombin Market: Key Segments
Based on the product type, the thrombin market has been segmented into bovine thrombin, human thrombin and recombinant thrombin. Each of the market segments have been extensively analyzed based on the market related factors such as increasing demand of thrombin products worldwide, and technological advancement. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.
The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the thrombin market and could influence the market in near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global thrombin market.
Global Thrombin Market: Regional Outlook
Geographically, thrombin market has been segmented into four major regions: North America, Europe, Asia Pacific, and Rest of World. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter’s five forces analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global thrombin market.
Companies Mentioned in Report
The report also profiles key players operating in the thrombin market which are Johnson & Johnson, Pfizer, Inc., Mallinckrodt Pharmaceuticals, Shanghai RAAS blood products co., Ltd., Japan Blood Products Organization and Mochida Pharmaceutical Co., Ltd.
The global thrombin market is segmented as follows:
Global Thrombin market, by Product
Bovine Thrombin
Human Thrombin
Recombinant Thrombin
Global Thrombin market, by Dosage Form
Powder Form
Solution Form
Others
Global Thrombin market, by End User
Hospitals
Diagnostics Centers & Clinics
Academics and Research Institutes
Global Thrombin market, by Geography
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of the Europe
Asia Pacific
Japan
China
Australia & New Zealand
Rest of Asia Pacific
Rest of World
1. Preface
1.1 Report Scope
1.2 Market Segmentation
1.3 Research Highlights
2. Assumptions and Research Methodology
2.1 Assumptions
2.2 Acronyms Used
2.3 Research Methodology
3. Executive Summary
4. Market Overview
4.1 Product Overview
4.2 Key Industry Developments
4.3 Global Thrombin Market Size (US$ Mn) Forecast
4.4 Market Opportunity Map
4.5 Market Indicators
4.6 Porter’s Analysis
4.7 Global Thrombin Market Outlook
5. Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Features of Ideal Hemostat at a glance
5.6 Key Brand Analysis
5.7 Regulatory Scenario
6. Global Thrombin Market Analysis, by Product
6.1 Key Findings
6.2 Introduction
6.3 Global Thrombin Market Value Share Analysis, by Product
6.4 Global Thrombin Market Forecast, by Product
6.4.1. Bovine Thrombin
6.4.2. Human Thrombin
6.4.3. Recombinant Thrombin
6.5 Global Thrombin Market Analysis, by Product
6.6 Global Thrombin Market Attractiveness Analysis, by Product
7. Global Thrombin Market Analysis, by Dosage Form
7.1 Key Findings
7.2 Introduction
7.3 Global Thrombin Market Value Share Analysis, by Dosage Form
7.4 Global Thrombin Market Forecast, by Dosage Form
7.4.1. Powder Forms
7.4.2. Solution Forms
7.4.3. Others
7.5 Global Thrombin Market Analysis, by Dosage Form
7.6 Global Thrombin Market Attractiveness Analysis, by Dosage Form
8. Global Thrombin Market Analysis, by End-user
8.1 Key Findings
8.2 Introduction
8.3 Global Thrombin Market Value Share Analysis, by End-user
8.4 Global Thrombin Market Forecast, by End-user
8.4.1. Hospitals
8.4.2. Diagnostics Centers & Clinics
8.4.3. Academics and Research Institutes
8.5 Global Thrombin Market Analysis, by End-user
8.6 Global Thrombin Market Attractiveness Analysis, by End-user
9. Thrombin Market Analysis, by Region
9.1 Global Thrombin Market Scenario
9.2 Introduction
9.3 Global Thrombin Market Value Share Analysis, by Region
9.3.1 North America
9.3.2 Europe
9.3.3 Asia Pacific
9.3.4 Rest of the World
9.4 Global Thrombin Market Forecast, by Region
9.5 Global Thrombin Market Attractiveness Analysis, by Region
10. North America Thrombin Market Analysis
10.1 Key Findings
10.2 North America Thrombin Market Overview
10.3 North America Thrombin Market Value Share Analysis, by Country
10.4 North America Thrombin Market Forecast, by Country
10.4.1. U.S.
10.4.2. Canada
10.5 North America Thrombin Market Value Share Analysis, by Product
10.6 North America Thrombin Market Forecast, by Product
10.7 North America Thrombin Market Value Share Analysis, by Dosage Form
10.8 North America Thrombin Market Forecast, by Dosage Form
10.9 North America Thrombin Market Value Share Analysis, by End-user
10.10 North America Thrombin Market Forecast, by End-user
10.11 North America Thrombin Market Attractiveness Analysis
11. Europe Thrombin Market Analysis
11.1 Key Findings
11.2 Europe Thrombin Market Overview
11.3 Europe Thrombin Market Value Share Analysis, by Country
11.4 Europe Thrombin Market Forecast, by Country
11.4.1 Germany
11.4.2 U.K.
11.4.3 France
11.4.4 Italy
11.4.5 Spain
11.4.6 Rest of the Europe
11.5 Europe Thrombin Market Value Share Analysis, by Product
11.6 Europe Thrombin Market Forecast, by Product
11.7 Europe Thrombin Market Value Share Analysis, by Dosage Form
11.8 Europe Thrombin Market Forecast, by Dosage Form
11.9 Europe Thrombin Market Value Share Analysis, by End-user
11.10 Europe Thrombin Market Forecast, by End-user
11.11 Europe Thrombin Market Attractiveness Analysis
12. Asia Pacific Thrombin Market Analysis
12.1 Key Findings
12.2 Asia Pacific Thrombin Market Overview
12.3 Asia Pacific Thrombin Market Value Share Analysis, by Country
12.4 Asia Pacific Thrombin Market Forecast, by Country
12.4.1 Japan
12.4.2 China
12.4.3 Australia & New Zealand
12.4.4 Rest of Asia Pacific
12.5 Asia Pacific Thrombin Market Value Share Analysis, by Product
12.6 Asia Pacific Thrombin Market Forecast, by Product
12.7 Asia Pacific Thrombin Market Value Share Analysis, by Dosage Form
12.8 Asia Pacific Thrombin Market Forecast, by Dosage Form
12.9 Asia Pacific Thrombin Market Value Share Analysis, by End-user
12.10 Asia Pacific Thrombin Market Forecast, by End-user
12.11 Asia Pacific Thrombin Market Attractiveness Analysis
13. Rest of the World Thrombin Market Analysis
13.1 Key Findings
13.2 Rest of the World Thrombin Market Overview
13.3 Rest of the World Thrombin Market Value Share Analysis, by Country
13.5 Rest of the World Thrombin Market Value Share Analysis, by Product
13.6 Rest of the World Thrombin Market Forecast, by Product
13.7 Rest of the World Thrombin Market Value Share Analysis, by Dosage Form
13.8 Rest of the World Thrombin Market Forecast, by Dosage Form
13.9 Rest of the World Thrombin Market Value Share Analysis, by End-user
13.10 Rest of the World Thrombin Market Forecast, by End-user
13.11 Rest of the World Thrombin Market Attractiveness Analysis
14. Competition Landscape
14.1 Competition Matrix
14.2 Thrombin Market: Heat Map Analysis by Company
14.3 Company Profiles
14.3.1 Johnson & Johnson Services, Inc.
14.3.1.1Company Details
14.3.1.1 Business Overview
14.3.1.2 Financial Overview
14.3.1.3 Strategic Overview
14.3.1.4 SWOT Analysis
14.3.2 Pfizer, Inc.
14.3.2.1 Company Details
14.3.2.2 Business Overview
14.3.2.3 Financial Overview
14.3.2.4 Strategic Overview
14.3.2.5 SWOT Analysis
14.3.3 Mallinckrodt Pharmaceuticals
14.3.3.1 Company Details
14.3.3.2 Business Overview
14.3.3.3 Financial Overview
14.3.3.4 Strategic Overview
14.3.3.5 SWOT Analysis
14.3.4 Shanghai RAAS blood products co., Ltd.
14.3.4.1 Company Details
14.3.4.2 Business Overview
14.3.4.3 Financial Overview
14.3.4.4 Strategic Overview
14.3.4.5 SWOT Analysis
14.3.5 Japan Blood Products Organization
14.3.5.1 Company Details
14.3.5.2 Business Overview
14.3.5.3 Strategic Overview
14.3.5.4 SWOT Analysis
14.3.6 Mochida Pharmaceutical Co., Ltd.
14.3.6.1 Company Details
14.3.6.2 Business Overview
14.3.6.3 Financial Overview
14.3.6.4 Strategic Overview
14.3.6.5 SWOT Analysis
14.3.7 BIOFAC A/S
14.3.7.1 Company Details
14.3.7.2 Business Overview
14.3.7.3 Strategic Overview
14.3.7.4 SWOT Analysis
14.3.8 Biomed-Lublin S.A.
14.3.8.1 Company Details
14.3.8.2 Business Overview
14.3.8.3 Financial Overview
14.3.8.4 Strategic Overview
14.3.8.5 SWOT Analysis
14.3.9 Hualan Biological Engineering, Inc.
14.3.9.1 Company Details
14.3.9.2 Business Overview
14.3.9.3 Strategic Overview
14.3.9.4 SWOT Analysis
Table 01: Global Thrombin Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 02: Global Thrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025
Table 02: Global Thrombin Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 03: Global Thrombin Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 04: North America Thrombin Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 05: North America Thrombin Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 06: North America Thrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025
Table 07: North America Thrombin Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 08: Europe Thrombin Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 09: Europe Thrombin Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 10: Europe Thrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025
Table 11: Europe Thrombin Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 12: Asia Pacific Thrombin Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 13: Asia Pacific Thrombin Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 14: Asia Pacific Thrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025
Table 15: Asia Pacific Thrombin Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 16: Rest of the World Thrombin Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 17: Rest of the World Thrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025
Table 18: Rest of the World Thrombin Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 19: Johnson & Johnson Services, Inc. Products & Services Offered
Table 20: Pfizer, Inc. Business Overview
Table 21: Mallinckrodt Pharmaceuticals Business Overview
Table 22: Shanghai RAAS blood products co., Ltd. Business Overview
Table 23: Japan Blood Products Organization Business Overview
Table 24: Mochida Pharmaceutical Co., Ltd. Business Overview
Table 25: BIOFAC A/S Business Overview
Table 26: Biomed-Lublin S.A. Business Overview
Table 27: Hualan Biological Engineering, Inc. Business Overview